203 related articles for article (PubMed ID: 12890392)
1. Effects of ursodeoxycholic acid on intrahepatic cholestasis in rats.
Li L; Xu X; Lu F; Zhao N
Chin Med J (Engl); 2003 Jul; 116(7):1099-103. PubMed ID: 12890392
[TBL] [Abstract][Full Text] [Related]
2. Choleretic effects of ursodeoxycholic acid on experimentally-induced intrahepatic cholestasis.
Mizoguchi Y; Miyajima K; Kioka K; Seki S; Kobayashi K; Morisawa S
Osaka City Med J; 1989 Nov; 35(2):83-91. PubMed ID: 2628845
[TBL] [Abstract][Full Text] [Related]
3. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid.
Glantz A; Marschall HU; Lammert F; Mattsson LA
Hepatology; 2005 Dec; 42(6):1399-405. PubMed ID: 16317669
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic effects of emodin on acute cholestatic hepatitis and mechanism thereof: experiment with rats].
Ding Y; Zhao L; Huang ZH; Mei H; Dong HF; Dong JH
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):699-703. PubMed ID: 19595067
[TBL] [Abstract][Full Text] [Related]
5. Effect of compound Yindan decoction on alpha-naphthylisothiocyanate-Induced acute intrahepatic cholestasis in rats.
Sun F; Li X; Xu C; Li P; Wu J; Sui J
J Tradit Chin Med; 2019 Jun; 39(3):315-323. PubMed ID: 32186003
[TBL] [Abstract][Full Text] [Related]
6. Ursodeoxycholic acid therapy in children with cholestatic liver disease.
Dinler G; Koçak N; Yüce A; Gürakan F; Ozen H
Turk J Pediatr; 1999; 41(1):91-8. PubMed ID: 10770681
[TBL] [Abstract][Full Text] [Related]
7. Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism.
Crosignani A; Podda M; Bertolini E; Battezzati PM; Zuin M; Setchell KD
Hepatology; 1991 Jun; 13(6):1076-83. PubMed ID: 2050325
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants.
Al-Hathlol K; Al-Madani A; Al-Saif S; Abulaimoun B; Al-Tawil K; El-Demerdash A
Singapore Med J; 2006 Feb; 47(2):147-51. PubMed ID: 16435058
[TBL] [Abstract][Full Text] [Related]
9. [Effects of ursodeoxycholic acid on the liver plasma membrane fluidity, hepatic glutathione concentration, hepatic estrogen receptors and progesterone receptors in pregnant rats with ethinylestradiol and progesterone induced intrahepatic cholestasis].
Shi QY; Kong BH; Ma KD; Zhang XL; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 2003 Nov; 38(11):680-2. PubMed ID: 14728856
[TBL] [Abstract][Full Text] [Related]
10. [Effects of ursodeoxycholic acid in patients with cholestasis of pregnancy].
Palma J; Reyes H; Ribalta J; Iglesias J; González M; Hernández I; Alvarez C; Molina C; Danitz AM
Rev Med Chil; 1991 Feb; 119(2):169-71. PubMed ID: 1824160
[TBL] [Abstract][Full Text] [Related]
11. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy.
Meng LJ; Reyes H; Axelson M; Palma J; Hernandez I; Ribalta J; Sjövall J
Hepatology; 1997 Dec; 26(6):1573-9. PubMed ID: 9398000
[TBL] [Abstract][Full Text] [Related]
12. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. A 12-year experience.
Zapata R; Sandoval L; Palma J; Hernández I; Ribalta J; Reyes H; Sedano M; Tohá D; Silva JJ
Liver Int; 2005 Jun; 25(3):548-54. PubMed ID: 15910492
[TBL] [Abstract][Full Text] [Related]
13. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis.
Jacquemin E; Hermans D; Myara A; Habes D; Debray D; Hadchouel M; Sokal EM; Bernard O
Hepatology; 1997 Mar; 25(3):519-23. PubMed ID: 9049190
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rg1 alleviates ANIT-induced intrahepatic cholestasis in rats via activating farnesoid X receptor and regulating transporters and metabolic enzymes.
Xiao Q; Zhang S; Ren H; Du R; Li J; Zhao J; Gao Y; Zhu Y; Huang W
Chem Biol Interact; 2020 Jun; 324():109062. PubMed ID: 32198087
[TBL] [Abstract][Full Text] [Related]
15. The biochemical and histopathological effects of ursodeoxycholic acid and metronidazole on total parenteral nutrition-associated hepatic dysfunction: an experimental study.
Günsar C; Melek M; Karaca I; Sencan A; Mir E; Ortaç R; Canan O
Hepatogastroenterology; 2002; 49(44):497-500. PubMed ID: 11995481
[TBL] [Abstract][Full Text] [Related]
16. Effects of diosgenin, a plant-derived steroid, on bile secretion and hepatocellular cholestasis induced by estrogens in the rat.
Accatino L; Pizarro M; Solís N; Koenig CS
Hepatology; 1998 Jul; 28(1):129-40. PubMed ID: 9657105
[TBL] [Abstract][Full Text] [Related]
17. S-adenosylmethionine in treatment of cholestasis after total parenteral nutrition: laboratory investigation and clinical application.
Li N; Zhang HH; Wang SH; Zhu WM; Ren JA; Li JS
Hepatobiliary Pancreat Dis Int; 2002 Feb; 1(1):96-100. PubMed ID: 14607634
[TBL] [Abstract][Full Text] [Related]
18. [Laboratory investigation and clinical application of S-adenosyl-L-methionine in the treatment of cholestasis after total parenteral nutrition].
Li N; Zhang H; Wang S; Zhu W; Ren J; Li J
Zhonghua Wai Ke Za Zhi; 2002 Jun; 40(6):407-10. PubMed ID: 12139793
[TBL] [Abstract][Full Text] [Related]
19. Clinical evidence of hepatoprotection induced by ursodeoxycholic acid.
Vincze A; Patty I; Jávor T; Pár A
Acta Physiol Hung; 1992; 80(1-4):369-74. PubMed ID: 1345203
[TBL] [Abstract][Full Text] [Related]
20. Lithocholic acid as a biomarker of intrahepatic cholestasis of pregnancy during ursodeoxycholic acid treatment.
Lucangioli SE; Castaño G; Contin MD; Tripodi VP
Ann Clin Biochem; 2009 Jan; 46(Pt 1):44-9. PubMed ID: 19103957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
